Literature DB >> 29510819

Primary Empty Sella Syndrome and the Prevalence of Hormonal Dysregulation.

Matthias K Auer1, Mareike R Stieg, Alexander Crispin, Caroline Sievers, Günter K Stalla, Anna Kopczak.   

Abstract

BACKGROUND: Empty sella is the neuroradiological or pathological finding of an apparently empty sella turcica containing no pituitary tissue. The prevalence of primary empty sella, i.e., empty sella without any discernible cause, is not precisely known; estimates range from 2% to 20%. Technical advances in neuroradiology have made empty sella an increasingly common incidental finding. It remains unclear whether, and to what extent, asymptomatic adult patients with an incidentally discovered empty sella should undergo diagnostic testing for hormonal disturbances.
METHODS: To answer this question, the authors carried out a systematic search in the PubMed and Web of Science databases for publications that appeared in the period 1995-2016 and that contained the search term "empty sella" (registration: PROSPERO 2015: CRD42015024550).
RESULTS: The search yielded 1282 hits. After the exclusion of duplicates, pediatric reports, case reports, and veterinary studies, 120 publications on primary empty sella syndrome (PES) were identified. 4 of these dealt with the prevalence of pituitary insufficiency in patients with PES as an incidental finding. Among patients with PES, the relative frequency of pituitary insufficiency in the pooled analysis was 52% (95% confidence interval [38; 65]).
CONCLUSION: The data on PES as an incidental finding are too sparse to enable any evidence-based recommendation on the potential indications for hormone testing or its nature and extent. We advise basic neuroendocrinological testing (fasting cortisol, free thyroxine [fT4], estradiol or testosterone, insulin-like growth factor 1 [IGF-1], and prolactin). There is an unexplained discrepancy between the reported high prevalence of pituitary insufficiency among persons with PES and its low prevalence in epidemiologic studies. We suspect that the former may be high because of selection bias in the publications that we reviewed, or else the latter may be erroneously low.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29510819      PMCID: PMC5842341          DOI: 10.3238/arztebl.2018.0099

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  26 in total

Review 1.  Primary empty sella: Why and when to investigate hypothalamic-pituitary function.

Authors:  A Giustina; G Aimaretti; M Bondanelli; F Buzi; S Cannavò; S Cirillo; A Colao; L De Marinis; D Ferone; M Gasperi; S Grottoli; T Porcelli; E Ghigo; E degli Uberti
Journal:  J Endocrinol Invest       Date:  2010-03-05       Impact factor: 4.256

2.  GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database.

Authors:  Chris J Gardner; Anders F Mattsson; Christina Daousi; Márta Korbonits; Maria Koltowska-Haggstrom; Daniel J Cuthbertson
Journal:  Eur J Endocrinol       Date:  2015-01-12       Impact factor: 6.664

3.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

4.  Pituitary autoimmunity is associated with hypopituitarism in patients with primary empty sella.

Authors:  I Lupi; L Manetti; V Raffaelli; L Grasso; C Sardella; M Cosottini; A Iannelli; M Gasperi; F Bogazzi; P Caturegli; E Martino
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

5.  Primary empty sella.

Authors:  Laura De Marinis; Stefania Bonadonna; Antonio Bianchi; Giulio Maira; Andrea Giustina
Journal:  J Clin Endocrinol Metab       Date:  2005-06-21       Impact factor: 5.958

6.  Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella.

Authors:  S Cannavò; L Curtò; M Venturino; S Squadrito; B Almoto; M C Narbone; R Rao; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

7.  Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults.

Authors:  Christa C van Bunderen; Carline J van den Dries; Martijn W Heymans; Anton A M Franken; Hans P F Koppeschaar; Aart J van der Lely; Madeleine L Drent
Journal:  Eur J Endocrinol       Date:  2014-05-06       Impact factor: 6.664

8.  The association of Cushing's disease and primary empty sella turcica.

Authors:  M P Manavela; C M Goodall; S B Katz; D Moncet; O D Bruno
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

9.  Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients.

Authors:  Annamaria Colao; Oana R Cotta; Diego Ferone; Maria L Torre; Francesco Ferraù; Carolina Di Somma; Mara Boschetti; Claudia Teti; Maria C Savanelli; Angela Alibrandi; Francesco Trimarchi; Salvatore Cannavò
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05-06       Impact factor: 3.478

10.  The empty sella: results of treatment in 76 successive cases and high frequency of endocrine and neurological disturbances.

Authors:  E Gallardo; D Schächter; E Cáceres; P Becker; E Colin; C Martínez; C Henríquez
Journal:  Clin Endocrinol (Oxf)       Date:  1992-12       Impact factor: 3.478

View more
  19 in total

1.  Rainbow Cup.

Authors:  Hans Baiker
Journal:  Dtsch Arztebl Int       Date:  2018-05-04       Impact factor: 5.594

2.  Overdiagnosis is Stressful.

Authors:  Wolfgang Freund; Thomas Nonn; Frank Weber
Journal:  Dtsch Arztebl Int       Date:  2018-05-04       Impact factor: 5.594

3.  Not an "All-or-Nothing" Principle.

Authors:  Eva R Kopka
Journal:  Dtsch Arztebl Int       Date:  2018-05-04       Impact factor: 5.594

4.  In Reply.

Authors:  Matthias K Auer; Günter Karl Stalla; Anna Kopczak
Journal:  Dtsch Arztebl Int       Date:  2018-05-04       Impact factor: 5.594

5.  [Empty sella syndrome and/or normal tension glaucoma?]

Authors:  Iva R Bartmann; Kai Kallenberg; Maged Alnawaiseh; Natasa Mihailovic
Journal:  Ophthalmologe       Date:  2022-04-28       Impact factor: 1.059

6.  A Multicenter Cohort Study in Patients With Primary Empty Sella: Hormonal and Neuroradiological Features Over a Long Follow-Up.

Authors:  Giulia Carosi; Alessandro Brunetti; Alessandra Mangone; Roberto Baldelli; Alberto Tresoldi; Giulia Del Sindaco; Elisabetta Lavezzi; Elisa Sala; Roberta Mungari; Letizia Maria Fatti; Elena Galazzi; Emanuele Ferrante; Rita Indirli; Emilia Biamonte; Maura Arosio; Renato Cozzi; Andrea Lania; Gherardo Mazziotti; Giovanna Mantovani
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

Review 7.  Epidemiology of Male Hypogonadism.

Authors:  Arthi Thirumalai; Bradley D Anawalt
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.748

Review 8.  Insights into non-classic and emerging causes of hypopituitarism.

Authors:  Flavia Prodam; Marina Caputo; Chiara Mele; Paolo Marzullo; Gianluca Aimaretti
Journal:  Nat Rev Endocrinol       Date:  2020-11-27       Impact factor: 43.330

9.  Primary hypothalamic lymphoma with clinical findings mimicking pituitary apoplexy: a case report.

Authors:  Mehmet Sözen; Büşra Yaprak Bayrak; Alev Selek; Zeynep Cantürk; Berrin Çetinarslan; Emre Gezer
Journal:  J Med Case Rep       Date:  2021-05-25

10.  Rare case of symptomatic empty sella syndrome in a patient treated with intrathecal chemotherapy for acute myeloid leukemia.

Authors:  Rahul Khamar; Raees Lunat; Jonathon Kyriakides; Ruhaid Khurram
Journal:  Radiol Case Rep       Date:  2020-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.